Completed NA INTERVENTIONAL 4-arm NCT02388035

Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis

Sponsor: Dr Ahmed Ali Elbaz

Conditions Spontaneous Bacterial Peritonitis

Interventions Cefotaxime

Updated 5 times since 2017 Last updated: Jun 3, 2015 Started: Mar 31, 2015 Primary completion: May 31, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02388035, this NA trial focuses on Spontaneous Bacterial Peritonitis and remains completed. Sponsored by Dr Ahmed Ali Elbaz, it has been updated 5 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dr Ahmed Ali Elbaz

Data source: Nasser Institute For Research and Treatment

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt